Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer

被引：0
|
作者：
G. C. Deng
Y. Lv
H. Yan
D. C. Sun
T. T. Qu
Y. T. Pan
Q. L. Han
G. H. Dai
机构：
[1] Nankai University,School of Medicine
[2] The Fifth Medical Center of PLA General Hospital,Senior Department of Oncology
来源：
BMC Cancer | / 21卷
关键词：
Nomogram; Pancreatic cancer; Prognosis; Laboratory parameters; Clinicopathological factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer
    Chen, Li-Tzong
    Macarulla, Teresa
    Blanc, Jean-Frederic
    Mirakhur, Beloo
    de Jong, Floris A.
    Belanger, Bruce
    Bekaii-Saab, Tanios
    Siveke, Jens T.
    CANCERS, 2019, 11 (08)
  • [22] A survival nomogram for castrated patients with progressive metastatic prostate cancer
    Smaletz, O
    Scher, HI
    Small, EJ
    Verbel, DA
    McMillan, A
    Regan, K
    Kelly, WK
    Kattan, MW
    JOURNAL OF UROLOGY, 2002, 167 (04): : 304 - 304
  • [23] Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer
    Fan, Mengjiao
    Deng, Guochao
    Ma, Yue
    Si, Haiyan
    Wang, Zhikuan
    Dai, Guanghai
    BMC CANCER, 2024, 24 (01)
  • [24] Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer
    Mengjiao Fan
    Guochao Deng
    Yue Ma
    Haiyan Si
    Zhikuan Wang
    Guanghai Dai
    BMC Cancer, 24
  • [25] Survival Benefit with the Combination of Docetaxel, Gemcitabine and Erlotinib in Advanced and/or Metastatic Pancreatic Cancer Patients
    Samelis, Georgios F.
    Ekmektzoglou, Konstantinos
    Tsiakou, Andriani
    Giannakaki, Styliani
    Konstadoulakis, Manoussos
    HEPATO-GASTROENTEROLOGY, 2011, 58 (110) : 1776 - 1781
  • [26] Locally advanced unresectable and metastatic pancreatic cancer predictors of survival
    Cipriano, A.
    Snores, A.
    Tavares, A.
    Iita, A. Mesc
    Sottomayor, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [27] Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer
    David, Goldstein
    Daniel, Von Hoff
    Chiorean, E.
    Michele, Reni
    Josep, Tabernero
    Ramesh, Ramanathan
    Julia, Wilkerson
    Marc, Botteman
    Abdalla, Aly
    Sandra, Margunato-Debay
    Brian, Lu
    Chrystal, Louis
    Markus, Renschler
    Desmond, McGovern
    Chee, Lee
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer
    Graesslin, Olivier
    Abdulkarim, Bassam S.
    Coutant, Charles
    Huguet, Florence
    Gabos, Zsolt
    Hsu, Limin
    Marpeau, Olivier
    Uzan, Serge
    Pusztai, Lajos
    Strom, Eric A.
    Hortobagyi, Gabriel N.
    Rouzier, Roman
    Ibrahim, Nuhad K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2032 - 2037
  • [29] Nomogram to Predict the Survival of Indonesian Bone-Metastatic Prostate Cancer Patients Treated with Androgen Deprivation Therapy
    Afriansyah, Andika
    Hamid, Agus Rizal Ah
    Mochtar, Chaidir Arif
    Umbas, Rainy
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 455 - 455
  • [30] SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients
    Arqueros, Cristina
    Salazar, Juliana
    Arranz, M. J.
    Sebio, Ana
    Mora, Josefina
    Sullivan, Ivana
    Tobena, Maria
    Martin-Richard, Marta
    Barnadas, Agusti
    Baiget, Montserrat
    Paez, David
    MEDICAL ONCOLOGY, 2017, 34 (08)
12345